Combination antiretroviral therapy in pregnant women with human immunodeficiency virus has dramatically decreased maternal-to-child transmission. Highly treatment-experienced pregnant patients have limited effective treatment options due to past toxicities and viral resistance.We present 8 pregnancies in 7 perinatally infected women successfully treated with salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of the Pediatric Infectious Diseases Society|
|State||Published - Sep 1 2014|
ASJC Scopus subject areas